Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

July 18, 2020
Open Access

Substandard Quality of the Antimicrobials Sold in the Street Markets in Haiti

Antibiotics
Théodule Jean-BaptisteAlbert Figueras
July 23, 2020

Clavulanic acid improves ethanol withdrawal symptoms in rats

Iranian Journal of Basic Medical Sciences
Ehsan MohebbiBahareh Amin
August 1, 2020
Open Access

Detection, Characterization and Antibiotic Susceptibility of Clostridioides (Clostridium) difficile in Meat Products

Food Science of Animal Resources
Karlo MuratogluHilal Colak
August 12, 2020

Structural basis and binding kinetics of vaborbactam in class A β-lactamase inhibition

Antimicrobial Agents and Chemotherapy
Orville A PembertonYu Wai Chen
July 29, 2020
Review

Recent advances in the development of β-lactamase inhibitors

The Journal of Microbiology
Shivakumar S Jalde, Hyun Kyung Choi
July 29, 2020

Therapeutic effect and mechanisms of the novel monosulfactam 0073

Antimicrobial Agents and Chemotherapy
Ying SunXiawei Wei
July 25, 2020
Case Report

Pediatric necrotizing soft tissue infection after elective surgery: A case report and literature review

International Journal of Pediatric Otorhinolaryngology
Lisa GheuensJoost van Dinther
July 19, 2020
Open Access

Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and Thrive

Antibiotics
M Courtney SafirChristopher M Rubino
August 7, 2020

Antimicrobial Susceptibility of Pathogenic Gram-positive Anaerobic Cocci: Data of a University Hospital in Turkey

Mikrobiyoloji bülteni
Öncü AkgülNurver Ülger Toprak
August 4, 2020
Open Access

Isolation of Serratia fonticola producing FONA, a minor extended-spectrum β-lactamase (ESBL), from imported chicken meat in Japan

Japanese Journal of Infectious Diseases
Koichi TanimotoHaruyoshi Tomita
August 9, 2020
Open Access

A novel hemA mutation is responsible for a small-colony-variant phenotype in Escherichia coli

Microbiology
Alasdair T M HubbardAdam P Roberts
July 30, 2020

In Vitro Activity of Ceftazidime-Avibactam Alone and in Combination with Amikacin Against Colistin-Resistant Gram-Negative Pathogens

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Tao ChenTieli Zhou

Sign up to follow this feed and discover related papers.

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2020 Meta ULC. All rights reserved
/feed-previews/beta-lactamase-inhibitors/e3c3f45e-0368-4b37-8375-68080d1877dd